4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-22-037145
Chief Medical Officer returned 668 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farwell Wildon Chief Medical Officer | 2022-06-14 | Returned to the company | −668 | $4.95 | $3,307 | 65,382 | D |
Loading xslF345X03/doc4.xml…